Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Ethinyl Estradiol on Polycystic Ovary Syndrome Women Undergoing Intrauterine Insemination

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* The patients with first treatment cycle~* Age between 25 and 30 years,~* Infertility for at least 2 years' duration,~* Oligomenorrhea or amenorrhea associated with a positive Progesterone challenge test~* Women with normal concentrations of prolactin, free thyroxin and thyroid-stimulating hormone (TSH)~Exclusion Criteria:~* Women whose partners had an abnormal semen analysis according to World Health Organization~* Women who had uterine or tubal abnormalities on hysterosalpingography, and women who had a body mass index of \>30 kg/m2.

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 30 Years
- Healthy Volunteers: f

Study Arms:
- clomiphene citrate and ethinyl estradiol (Type: EXPERIMENTAL): Clomiphene citrate is used in combination of ethinyl estradiol (0.05 mg for 5 days) for induction ovulation of polycystic ovary syndrome women undergoing intrauterine insemination
- clomiphene citrate and placebo (Type: ACTIVE_COMPARATOR): Clomiphene citrate is used in combination of placebo (for 5 days) for induction ovulation of polycystic ovary syndrome women undergoing intrauterine insemination

Based on this trial design, predict the completion outcome and termination type (if applicable).